Safety Shot (NASDAQ:SHOT - Get Free Report)'s stock had its "sell (d-)" rating reissued by investment analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.
Separately, Wall Street Zen upgraded shares of Safety Shot from a "sell" rating to a "hold" rating in a research note on Saturday, August 16th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of "Sell".
Get Our Latest Report on Safety Shot
Safety Shot Stock Performance
Shares of NASDAQ:SHOT opened at $0.42 on Wednesday. Safety Shot has a 52 week low of $0.23 and a 52 week high of $1.34. The company's fifty day moving average is $0.49 and its 200-day moving average is $0.45.
Safety Shot (NASDAQ:SHOT - Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported ($0.03) EPS for the quarter. The firm had revenue of $0.45 million for the quarter.
Institutional Trading of Safety Shot
An institutional investor recently raised its position in Safety Shot stock. Tyche Wealth Partners LLC increased its holdings in shares of Safety Shot, Inc. (NASDAQ:SHOT - Free Report) by 142.9% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 85,000 shares of the company's stock after purchasing an additional 50,000 shares during the quarter. Tyche Wealth Partners LLC owned 0.08% of Safety Shot worth $28,000 as of its most recent filing with the SEC. 12.55% of the stock is owned by institutional investors.
Safety Shot Company Profile
(
Get Free Report)
Safety Shot, Inc, a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Safety Shot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Safety Shot wasn't on the list.
While Safety Shot currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.